Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice
Agah, R.; Malloy, B.; Sherrod, A.; Mazumder, A.
Cancer Research 48(8): 2245-2248
1988
ISSN/ISBN: 0008-5472 PMID: 3127048 Document Number: 306130
The problem associated with lymphokine (gamma-interferon, interleukin-2, and tumor necrosis factor) therapy in cancer is that high toxic doses of these lymphokines must be administered for any significant antitumor results. Therefore this study was undertaken to investigate the antitumor efficacy of these lymphokines in a disseminated pulmonary metastasis when used in combination with each other at dosages well below the toxic level. The role of the immune system of the host, sequencing of lymphokines, and histopathological aspects of lymphokine therapy were also investigated.
Document emailed within 1 workday
Related Documents
Hori, K.; Ehrke, M.J.; Mace, K.; Mihich, E. 1987: Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon Cancer Research 47(22): 5868-5874Togashi, H.; Ohno, S.; Matsuo, T.; Watanabe, H.; Saito, T.; Shinzawa, H.; Takahashi, T. 2000: Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress Research Communications in Molecular Pathology and Pharmacology 107(5-6): 407-417
Robak, E.; Sysa-Jedrzejewska, A.; Dziankowska, B.; Torzecka, D.; Chojnowski, K.; Robak, T. 1998: Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity Archivum Immunologiae et Therapiae Experimentalis 46(6): 375-380
Le, J.M.; Vilcek, J. 1987: Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor Journal of Immunology 139(10): 3330-3337
Takahashi, M.; Oshimi, K.; Mizoguchi, H. 1990: Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha Experimental Hematology 18(5): 395-399
Allione, A.; Consalvo, M.; Nanni, P.; Lollini, P.L.; Cavallo, F.; Giovarelli, M.; Forni, M.; Gulino, A.; Colombo, M.P.; Dellabona, P. 1994: Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants Cancer Research 54(23): 6022-6026
Herrmann, F.; Gebauer, G.; Lindemann, A.; Brach, M.; Mertelsmann, R. 1989: Interleukin-2 and interferon-gamma recruit different subsets of human peripheral blood monocytes to secrete interleukin-1 beta and tumour necrosis factor-alpha Clinical and Experimental Immunology 77(1): 97-100
Talmadge, J.E.; Tribble, H.R.; Pennington, R.W.; Phillips, H.; Wiltrout, R.H. 1987: Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice Cancer Research 47(10): 2563-2570
Dinarello, C.A.; Okusawa, S.; Gelfand, J.A. 1989: Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition Progress in Clinical and Biological Research 286: 243-263
Rook, A.H.; Hooks, J.J.; Quinnan, G.V.; Lane, H.C.; Manischewitz, J.F.; Macher, A.M.; Masur, H.; Fauci, A.S.; Djeu, J.Y. 1985: Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism Journal of Immunology 134(3): 1503-1507
Yang, F.C.; Yabuhara, A.; Koike, K. 1994: Absence of responsiveness to interferon-gamma but not to interleukin 2 and depressed recycling as natural killer cell abnormalities in childhood lymphohistiocytic syndrome International Journal of Hematology 59(4): 273-280
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Miller, V.E.; Pohajdak, B.; Greenberg, A.H. 1983: Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance Journal of the National Cancer Institute 71(2): 377-384
Onozaki, K.; Urawa, H.; Tamatani, T.; Iwamura, Y.; Hashimoto, T.; Baba, T.; Suzuki, H.; Yamada, M.; Yamamoto, S.; Oppenheim, J.J. 1988: Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor Journal of Immunology 140(1): 112-119
Van Damme, J.; De Ley, M.; Van Snick, J.; Dinarello, C.A.; Billiau, A. 1987: The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor Journal of Immunology 139(6): 1867-1872
Ai, Y.; Liu, S.-y. 2004: Influence of transforming growth factor-beta2 on production of tumor necrosis factor-alpha and interferon-gamma from placenta of intrahepatic cholestasis of pregnancy Zhonghua Fu Chan Ke Za Zhi 39(5): 322-325
Shiloni, E.; Lafreniere, R.; Mulé, J.J.; Schwarz, S.L.; Rosenberg, S.A. 1986: Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice Cancer Research 46(11): 5633-5640
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Pardo-Govea, T.; Callejas, D.; Núñez-Troconis, Jé.; Araujo, M.; Costa, L.; Pons, Héctor.; Delgado, M.; Monsalve, F. 2005: Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report Investigacion clinica 46(1): 5-13
Pisa, P.; Stenke, L.; Bernell, P.; Hansson, M.; Hast, R. 1990: Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients Anticancer Research 10(3): 817-820